140 related articles for article (PubMed ID: 32074321)
21. Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models.
Christoph T; Kögel B; Strassburger W; Schug SA
Drugs R D; 2007; 8(1):51-7. PubMed ID: 17249849
[TBL] [Abstract][Full Text] [Related]
22. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain.
Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G
Pain; 2005 Aug; 116(3):347-358. PubMed ID: 15982817
[TBL] [Abstract][Full Text] [Related]
23. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
25. Synergistic interaction between intrathecal ginsenosides and morphine on formalin-induced nociception in rats.
Yoon MH; Kim KS; Lee HG; Kim CM; Kim WM; Choi JI; Kim YO
J Pain; 2011 Jul; 12(7):774-81. PubMed ID: 21459679
[TBL] [Abstract][Full Text] [Related]
26. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats.
Chen X; Geller EB; Rogers TJ; Adler MW
Brain Res; 2007 Jun; 1153():52-7. PubMed ID: 17459345
[TBL] [Abstract][Full Text] [Related]
27. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
Wang D; Chen T; Zhou X; Couture R; Hong Y
Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
[TBL] [Abstract][Full Text] [Related]
28. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury.
Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
Neurosci Lett; 1995 Oct; 199(2):83-6. PubMed ID: 8584249
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury.
Aceves M; Mathai BB; Hook MA
Spinal Cord; 2016 Oct; 54(10):767-777. PubMed ID: 26927293
[TBL] [Abstract][Full Text] [Related]
31. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal morphine and ketorolac analgesia after surgery: comparison of spontaneous and elicited responses in rats.
Martin TJ; Zhang Y; Buechler N; Conklin DR; Eisenach JC
Pain; 2005 Feb; 113(3):376-385. PubMed ID: 15661447
[TBL] [Abstract][Full Text] [Related]
33. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
35. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.
Wala EP; Sloan PA; Holtman JR
J Opioid Manag; 2011; 7(5):377-89. PubMed ID: 22165037
[TBL] [Abstract][Full Text] [Related]
36. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
37. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
39. The effect of lesions of the dorsolateral funiculus on formalin pain and morphine analgesia: a dose-response analysis.
Abbott FV; Hong Y; Franklin KBJ
Pain; 1996 Apr; 65(1):17-23. PubMed ID: 8826485
[TBL] [Abstract][Full Text] [Related]
40. Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia.
Lunzer MM; Yekkirala A; Hebbel RP; Portoghese PS
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6061-5. PubMed ID: 17389363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
